Abstract
The 1-benzyl and 1-methyl congeners of trimetoquinol were tested for antagonism of receptors which mediate inotropy and chronotropy in the isolated perfused rabbit heart. 1-Benzyltrimetoquinol was found to be a blocker of resting, isoproterenol- and dobutamine-stimulated inotropy at concentrations (10-7-10-5M) which did not significantly affect chronotropy ( > 10-5M). 1-Methyltrimetoquinol was found to be a partial agonist in the resting myocardium, weakly blocking inotropy and chronotropy at doses of 10-7-10-5M. At a concentration of 10-4M, 1-methyltrimetoquinol was an agonist of both chronotropy and inotropy. These stimulatory properties appear to be direct (not affected by prior reserpinization) and antagonized by propranolol. In the isoproterenol-stimulated heart, 1-methyltrimetoquinol was a specific negative inotropic agent at doses (10-7-10-5M) above which agonist properties were manifest. At 10-4M, 1-methyltrimetoquinol acted synergistically with isoproterenol to produce positive inotropy and chronotropy significantly greater than that of isoproterenol alone. Currently, it is believed that the receptors which mediate inotropy and chronotropy are beta adrenergic in nature. Thus, it would appear that 1-benzyltrimetoquinol is a specific antagonist of those beta-receptors which mediate inotropy, while 1-methyltrimetoquinol is a partial agonist of both inotropic and chronotropic beta-receptors. Further, the response to these compounds does not appear to be proportionate in various regions of the myocardium.
Original language | English |
---|---|
Pages (from-to) | 2433-2439 |
Number of pages | 7 |
Journal | Life Sciences |
Volume | 24 |
Issue number | 26 |
DOIs | |
State | Published - Jun 25 1979 |
Bibliographical note
Funding Information:In part supported by USPHS Grants NS 10896 and HL
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- General Biochemistry, Genetics and Molecular Biology